Home Tools

Cart

Pelitinib

Catalog No. T2327 CAS 257933-82-7

Synonyms: EKB-569, WAY-EKB 569

Pelitinib (EKB-569) (EKB-569) is an effective irreversible EGFR inhibitor (IC50: 38.5 nM).

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Pelitinib, CAS 257933-82-7

Pack Size	Availability	Price/USD
5 mg	In stock	$ 43.00
10 mg	In stock	$ 61.00
25 mg	In stock	$ 107.00
50 mg	In stock	$ 133.00
100 mg	In stock	$ 198.00
500 mg	In stock	$ 490.00
1 mL * 10 mM (in DMSO)	In stock	$ 48.00

Bulk Inquiry

Select Batch

Purity: 99.86%

Purity: 99%

Purity: 98.37%

Biological Description

Chemical Properties

Storage & Solubility Information

Description	Pelitinib (EKB-569) (EKB-569) is an effective irreversible EGFR inhibitor (IC50: 38.5 nM).
Targets&IC50	EGFR:38.5 nM
In vitro	In the A431 xenograft model targeting EGFR, Pelitinib (10 mg/kg, p.o.) effectively inhibits EGFR phosphorylation, achieving a 90% inhibition within 1 hour and maintaining over 50% inhibition after 24 hours. In the mouse airway epithelial cell remodeling model, which can be induced by viral infection and is characterized by a delayed yet permanent transition to goblet cell metaplasia, Pelitinib (20 mg/kg/day) completely blocks the increase of ciliated cells and the decrease of Clara cells, thereby correcting epithelial cell remodeling from three different aspects and significantly inhibiting the occurrence of goblet cells. Additionally, Pelitinib (20 mg/kg/day) inhibits 87% of tumor occurrence in APCMin/+ mice, which is comparable to the effect of a double dose of EKI-785 (40 mg/kg/day), consistent with its higher in vivo activity. Pelitinib exhibits selective inhibitory effects on EGFR signaling in airway epithelial cells in vivo.
In vivo	Pelitinib (75-500 nM) specifically inhibits the activation of AKT and ERK1/2 without affecting the NF-κB pathway. In normal human keratinocytes, Pelitinib effectively inhibits TGF-α-mediated EGFR activation (IC50: 56 nM) and the activation of STAT3 and ERK1/2 (IC50: 60 nM and 62 nM, respectively). It also suppresses EGF-induced EGFR phosphorylation (IC50: 20-80 nM) and STAT3 phosphorylation (IC50: 30-70 nM) in both A431 cells and normal human keratinocytes. Moreover, Pelitinib significantly inhibits the proliferation of normal human keratinocytes (IC50: 61 nM), A431 (IC50: 125 nM), and MDA-468 (IC50: 260 nM) tumor cells, but shows lower activity against MCF-7 cells (IC50: 3.6 μM).
Kinase Assay	Autophosphorylation of EGFR in cells: For experiments using cells in culture, A431 cells are treated with various concentrations of Pelitinib for 2.75 hours before co-incubation with 100 ng/mL EGF for 0.25 hour. Cells are washed twice with cold phosphate-buffered saline (PBS) before adding to lysis buffer (10 mM Tris, pH 7.5, 5 mM ethylenediamine tetra-acetic acid (EDTA), 150 mM NaCl, 1% Triton X-100, 1% Sodium deoxycholate, 0.1 % SDS, 1 mM PMSF, 10 mg/mL pepstatin A, 10 mg/mL leupeptin, 20 KIU/mL aprotinin, 2 mM sodium orthovanadate, and 100 mM sodium fluoride) for 20 minutes on ice, before immunoprecipitation and SDS-PAGE-immunoblotting. For immunoprecipitation, cultured cells are placed in cold lysis buffer and immediately homogenized on ice with a polytron with several pulses. The homogenate is first centrifuged at 2500 rpm (20 minutes, 4 °C) and then again at 14,000 rpm in a microcentrifuge (10 minutes, 4 °C). Supernatants (1000 μg protein) are incubated for 2 hours at 4 °C with 15 mL of EGFR polyclonal antibody. After 2 hours, 50 μL of protein G plus/protein A agarose beads is added and incubated with constant rotation for 2 hours at 4 °C. After washing with lysis buffer, beads are boiled for 2 minutes in Laemmli sample buffer. Proteins are then resolved by SDS-PAGE, transferred to immobilon membrane and probed overnight with an anti-phosphotyrosine antibody conjugated with horseradish peroxidase (HRP). Membranes are developed using the ECL reagent. Total EGFR protein is determined by stripping membranes and re-probing with receptor-specific antibodies. Quantitation of bands is done by densitometry, using ImageQuant software with a Molecular Dynamics laser transmittance scanner.
Cell Research	Cells are seeded in 96-well dishes, and after 2 hours, Pelitinib is added and incubated for 5 days. After incubation, the medium is removed from each well and fresh medium (150 μL) + 1 mg/mL MTT solution (50 μL) is added. After incubation for 2 hours at 37 °C, the medium is replaced with 150 μL DMSO, and absorbance at 540 nm in each well is determined. The IC50 is calculated by linear regression of the data. (Only for Reference)

Synonyms	EKB-569, WAY-EKB 569
Molecular Weight	467.92
Formula	C24H23ClFN5O2
CAS No.	257933-82-7

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

H2O: < 1 mg/mL (insoluble or slightly soluble)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

DMSO: 11 mg/mL (23.5 mM)

References and Literature

1. Torrance CJ, et al. Nat Med, 2000, 6(9), 1024-1028. 2. Nunes M, et al. Mol Cancer Ther, 2004, 3(1), 21-27. 3. Tyner JW, et al. J Clin Invest, 2006, 116(2), 309-321.

Citations

1. Li J, Zheng M, Xu Y, et al.Target Proteins Profiling of Irreversible Kinase Inhibitor Pelitinib and Discovery of Degradation of PRDX4 by Label Free Chemoproteomics.Journal of Pharmaceutical and Biomedical Analysis.2023: 115398.

Related compound libraries

This product is contained In the following compound libraries：

Anti-Cancer Clinical Compound Library Anti-Cancer Drug Library Tyrosine Kinase Inhibitor Library Kinase Inhibitor Library Inhibitor Library Highly Selective Inhibitor Library Anti-Cancer Active Compound Library Drug Repurposing Compound Library Stem Cell Differentiation Compound Library MAPK Inhibitor Library

Related Products

Related compounds with same targets

Sanguinarine chloride EAI045 Almonertinib mesylate BKI-1369 RTC-5 CL-387785 Tyrphostin B44, (+) enantiomer Poziotinib

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step Two: Enter the in vivo formulation

% DMSO+

% +

% Tween 80+

% ddH₂O

%DMSO+

Calculate Reset

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL)，Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation：Take μL DMSO master liquid, next add μL PEG300， mix and clarify, next add μL Tween 80，mix and clarify, next add μL ddH₂O, mix and clarify.

Note:

Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Calculator

Molarity Calculator

Dilution Calculator

Reconstitution Calculation

Molecular Weight Calculator

Mass

Concentration

Volume

Molecular Weight

Molarity Calculator allows you to calculate the

Mass of a compound required to prepare a solution of known volume and concentration
Volume of solution required to dissolve a compound of known mass to a desired concentration
Concentration of a solution resulting from a known mass of compound in a specific volume

See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

Concentration (Start)

Volume (Start)

Concentration (End)

Volume (End)

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Molecule Formula

Molecular Weight g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Pelitinib 257933-82-7 Angiogenesis JAK/STAT signaling MAPK Tyrosine Kinase/Adaptors Raf EGFR MEK Src inhibit EKB569 HER1 Epidermal growth factor receptor Inhibitor WAY-EKB-569 ErbB-1 WAY-EKB569 EKB 569 EKB-569 WAY-EKB 569 inhibitor

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.